Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['cilta cel', 'cartitude-4', 'mmsm', 'cartitude']
is it time to bring the car home early? cartitude-4 demonstrates dramatic benefit of cilta cel over standard of care in 1-3 prior lines. may also signal less toxicity in earlier lines. impressive. #asco23 #mmsm #mediq23asco 
Hematologist, Myeloma Expert, Communication Enthusiast. Professor at TGen/City of Hope and Chief Medical Officer of the International Myeloma Foundation